Memantine Prodrug as a New Agent for Alzheimer’s Disease

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-40925-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Experience of Memantine in Alzheimer’s Disease

European Neurological Review
Neurology
2008English

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology
Pharmacology
2019English

Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

The Prodrug of 7,8-Dihydroxyflavone Development and Therapeutic Efficacy for Treating Alzheimer’s Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

A Template for New Drugs Against Alzheimer’s Disease

Cell
BiochemistryGeneticsMolecular Biology
2013English

Drosophila Melanogaster as a Model Organism for Alzheimer’s Disease

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2013English

Fyn Kinase Inhibition as a Novel Therapy for Alzheimer’s Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2014English

Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease

Movement Disorders
Neurology
2012English

Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy